L1: cardiovascular physiology
	- cardiac cycle phases

	- 4th heart sound for decreased LV compliance (LVH)
	- A2 before P2, widens on inspiration
	- 3rd heart sound ventricular volume overload

M1: cardiovascular physiology
	main:
	- arteries:
		- α1 + β2 receptors
		- arterioles highest region of resistance
	- veins:
		- α1 receptors
		- contain 60% of blood volume
	- right heart symptoms:
		- peripheral edema
		- ascites
		- RUQ pain from liver congestion
	- left heart failure:
		- dyspnea
		- cough +/- hemoptysis
		- fatigue
		- organ dysfunction
		- cold limbs

	- cardiac cyle:
		- diastole - atrial contraction:
			- P wave is last phase of diastole
			- atrial depolarization + contraction
			- PLA -> venous a wave
			- S4 if decreased LV compliance (LVH)
		- systole - isovolumetric contraction:
			- QRS is activation of ventricles
			- S1 = MV closing, AV remains closed
		- systole - early ventricular ejection:
			- AV opens, A pressure rises
			- venous C wave (TV bulge into RA)
		- systole - reduced ventricular ejection
			- T wave is ventricular repolarization
			- A pressure falls
		- diastole - isovolumetric ventricular relaxation:
			- ventricles fully repolarized
			- LV pressure drops
			- S2 (A2 then P2 w/ inspiration) = AV closes
			- venous V wave as RA fills
			- dicrotic notch due to AV closure
		- diastole - rapid ventricular filling:
			- ventricular pressure at lowest
			- MV opens
			- ventricular volume increases
			- S3 if volume overload (non-compliant ventricle)
		- diastole - reduced ventricular filling:
			- longest part of cycle
			- slower ventricular filling
	- preload:
		- measured by end-diastolic volume or pressure
		- increased by:
			- increased central venous pressure
			- increased ventricular compliance (stiff)
			- increased atrial contraction
			- reduced heart rate (more filling)

	- afterload:
		- resistance to pump
		- wall stress = P x r / 2h
		- increased by:
			- increased pressure load
				- htn
				- aortic stenosis
			- increased chamber size - dilated LV
		- decreased by:
			- increased LV thickness

	- contractility:
		- myocardial force
		- increased contractility
			- sympathetic
			- inotropes - digoxin
			- hypercalcemia
		- decreased contractility:
			- parasympathetic
			- negative inotropes: β-blockers, CCBs
			- hypoxia
			- acidosis
			- hyperkalemia

	- shock:
		- distributive (setic, non-septic)
			- peripheral vasodilation
			- preload decreases, SVR decreases -> CO increases
		- cardiogenic (cardiomyopathic, arrhythmogenic, mechanical)
			- pump failure
			- CO decreases, preload increases -> SVR increases
		- hypovolemic (hemorrhagic, non-hemorrhagic)
			- reduced intravascular volume
			- preload decreases + CO decreases -> SVR increases
		- obstructive (pulmonary vascular, mechanical)
			- extracardiac casues of pump failure
			- PE, PH
				- preload decreases + CO decreases -> SVR increases
			- pericardial / tamponade
				- preload increases + CO decreases -> SVR increases

L2: regulation of blood pressure
	- bp elevated: 120-129 mmhg or < 80 mmhg
	- htx stage 1: 130-139 mmhg or 80-89 mmhg
	- htx stage 1: >140 mmhg or >90 mmhg

	bp regulators:
		- autonomic nervous system
			- increases BP
			- sympathetic nerves
			- adrenal glands
			- baroreceptors
				- carotid (CN IX)
				- aortic arch (CN X)
				- stimulation decreases blood pressure
					- stimulates cardiac decelerator
					- inhibits cardiac accelerator + vasoconstriction
			- renin release from kidneys
		- RAAS
			- increases Na + water retention
			- increases BP
			- kidney control
			- pathway:
				- prorenin --[decreased renal perfusion pressure]-> renin (kidney)
				- angiotensiogen (liver) --[renin]--> antiotensin I
				- angiotensin I --[ACE]--> antiotensin II
			- antiotensin II:
				- stimulates aldosterone synthesis (adrenal)
				- stimulates epinephrine release (adrenal)
				- vasoconstriction
				- Na + HC03- (increases CO) uptake (increased Na+ H+ exchange in renal proximal tubule)
				- stimulates ADH (hypothalamus)
				- stimulates thirst (hypothalamus)
				- stimulates vasopressin release (brain)
				- increases contractility + ventricular hypertrophy (heart)

		- chemoreceptors
			- increases BP
			- carotid + aortic bodies
				- sense decrease in O2, increase in CO2, and decrease in pH
				- increase vasoconstriction (brain -> autnomic)
			- central
				- in brain
				- sense pCO2 or pH (minor sense of PO2)
				- increases sympathetic outflow (medullary vascular centers)
		- ADH
			- increases BP
			- increased by angiotensin II and serum osmolarity
			- posterior pituitary gland
			- vasoconstriction (V1 receptors)
			- collecting duct water reabsorption (V2 receptors)
		
		- cardiopulmonary baroreceptors
			- lowers BP
			- veins, atria, P artery
			- increase blood volume -> increase venous pressure -> baroreceptors fire
			- secrete ANP (atrial natriuretic peptide)
				- vasodilation
				- vasodilation in kidney (by sympathetic inhibition)-> Na+ and water excretion
			- decreases ADH
			- increases heart rate (CN X -> nucleus tractus solitarius)
				- bainbridge reflex
					- increases CO
					- increases renal perfusion
					- increases Na+ + water excretion (lowers BP)

L3: vasculature drugs
	- look at cardiology drugs sheet

L4: heart and lung
	- heart values:
		- RA: 2-8
		- LA: 2-10
		- RV: 15-30 : 2-8
		- PA: 15-30 : 4-12
		- LV: 100-140 : 3-12
	- pulmonary htx
		- venous: mean PAP > 25mmhg and PCWP > 15 mmhg
		- arterial: mean PAP > 25mmhg and PCWP > 15 mmhg + no left side heart disease
	- non-cardiogenic pulmonary edema -> ARDS

	- diseases:
		- pulmonary vascular redistribution
			- apical vascular redistribution
			- may have SOB
		- pulmonary interstitial edema
			- haziness of vessels + kerley B lines
			- will have SOB
		- pulmonary edema
			- opaque air spaces
			- butterfly around hila
			- pleural effusions
			- rales, wheezing, and/or frothy pink sputum
		
		- pulmonary congestion
			- dyspnea
			- orthopnea
			- paroxysmal nocturnal dyspnea
			- hemoptysis
			- cough
			- fatigue
		- systemic congestion
			- edema
			- ascites
			- RUQ pain (liver congestion)
			- cyanosis

L5: antithrombotic therapy
	- thrombosis
		- primary hemostasis: platelet aggregation
		- secondary hemostasis: coagulation proteins
		- tertiary hemostasis: clot dissolution, plasmin major enzyme

L6: pathophysiology of heart failure I:
	main:
	- heart failure
		- syndrome
		- classifications:
			- NYHA
				- I: no limitations of activity
				- II: mild symptoms in activity
				- III: marked limitations of activity
				- IV: severe limitations, symptoms at rest
			- ACC/AHA
				- A: high risk for HF
				- B: asymptomatic HF (NYHA I)
				- C: symptomatic HF
				- D: end-stage HF
		- pressure volume loops
			- preload
				- change position on EDPVR curve
				- wall stress at end-diastole
				- frank starling curve
					- decrease preload too much -> decrease SV -> hypotension
					- increase preload too much -> elevated PCWP -> pulmonary congestion
			
			- afterload
				- change position of ESPVR curve
				- aterial elastance Ea = Pes / SV = CO * TPR / SV = HR * TPR
				- wall stress at end-systole

			- contractility
				- slope ESPVR = dESPVR/dv = Ees
					- Ees ~ ventricular contractility
					- inotropes increase Ees slope, more contractility
						- higher pressures for same volume
				- frank-starling curve
					- increase contractility -> higher SV w/ same pressure

			- capacitance
				- volume at specific pressure
				- point on EDPVR
				- diastolic property of heart

			- compliance
				- inverse of ventricle stiffness
				- slope at point on EDPVR

			- wall stress
				- σ = P x r / 2h

L7: pathophysiology of heart failure II
	main:
	- activated systems in heart failure
		- neurohormonal
			- RAS and SNS activation
			- effects
		- adrenergic
			- increased sympathetic outflow
			- increased adrenergic tone
			- activation of RAS
	- natriuretic peptides
		- released by increased ventricular stretch / load
		- ANP + BNP -> decrease ventricular stretch / load
			- increase natriueresis
			- increase diuresis
			- increase vasodilation
			- decrease RAAS
	- chart on short/long term effects
	
	- diastolic HF - impaired filling
		- concentric hypertrophy (volume decreases)
		- #1 cause: htn
		- elderly, female
		- EF > 40%, preserved/normal EF
		- decreased capacitance, EDPVR shifts left -> smaller PV loop
			- SV -> smaller
		- causes:
			- impaired diastolic filling
				- LVH, restrictive cardiomyopathy, myocardial fibrosis
				- transienst MI
				- pericardial constriction or tamponade
		- signs:
			- EKG: LVH
			- CXR: congestion + normal heart size
			- S4

	- systolic HF - impaired contraction
		- eccentric hypertrophy (volume constant)
		- #1 cause: CAD (volume overload)
		- 50-70 yo, male
		- EF < 40%, reduced EF
		- decreased contractility -> ESPVR shifts right, decreased slope -> EDPVR shifts right (eccentric remodeling)
			- PV loop shrinks and gets pushed rightward (volumes increase by SV -> same or smaller)
		- causes:
			- increased afterload: aortic stenosis or htn
			- impaired contractility
				- MI, MV regurg, AV regurg, dilated cardiomyopathies
		- signs:
			- EKG: +/- LVH
			- CXR: cardiomegaly + congestion
			- S3

	- PV loops of HF
		- increased blood volume (preload)
			- shifts PV loop to right (increased volumes)
			- causes: MR regurg, AV regurg, volume overload, LtR shunts, chronic kidney disease

		- increased resistance (afterload)
			- process:
				- Ea point increases
				- diastolic dysfunction
				- remodeling
				- PV loop move right and gets taller, higher pressures and volumes
			- causes: AV stenosis, aortic coarctation, htn 

		- decreased contractility
			- process:
				- ESPVR slope gets smaller
				- PV loop shifts right and shrinks
				- MI + HF
				- remodeling
				- PV loops gets shift even more right, stays small
			- causes:
				- ischemic cardiomyopathy
				- myocarditis
				- toxins: anthracycline, alcohol, cocaine

		- decreased filling
			- process:
				- remodeling
				- hypertrophic cardiomyopathy
				- PV loop shifts along EDPVR -> bigger systolic volume + pressure
			- causes:
				- MV stenosis:
				- constriction
				- restrictive cardiomyopathy
				- cardiac tamponade
				- hypertrophic cardiomyopathy
				- infiltrative cardiomyopathy
	- high output failure
		- increased demands or decreased O2 delivery ability

	- decompensated HF
		- congestion (wet):
			- orthopnea
			- JVP
			- S3 (most specific) or load P2
			- edema / ascites
			- HJR

		- perfusion (cold)
			- narrow pulse pressure
			- cool extremities
			- sleepy / obtunded
			- hypotension
			- decreasing Na
			- increasing renal fx

		- precipitants:
			- ischemia, htn, anemia, volume overload, increased metabolic demand, etc

L8-9: medical treatment of heart failure
	main:
	- heart failure with reduced ejection fraction (HFrEF)
		- acute:
			- goals: decongest + improve perfusion
			- decongestion:
				- decrease preload:
					- diuretics
						- paradigm:
							- loops first choice, thiazides as potentiators, K-sparing to fix hypokalemia
						- loop diuretics
						- thiazide diuretics
						- K-sparing diuretics

					- venodilators

			- improve perfusion
				- decrease afterload
					- arterial vasodilators
						- nitroprusside
						- nitroglycerine

				- increase contractility
					- inotropes:
						- dobutamine
						- milrinone
						- dopamine
						- digoxin

			- paradigm:
				- wet -> diurectics + vasodilators
				- cold -> inotropics
				- cold + wet -> vasodilators first -> rest

		- chronic stable:
			- goals: reverse remodeling + arrest HF milieu, DM, htn, etc
			- RAAS inhibition:
				- ACE inhibitors (20% mortality reduction)
				- ARB inhibitors (15% mortality reduction)
			
			- venodilators
				- hydralazine-isordil
					- if BP high enough

			- LCZ696 (ARNI)
				- 38% mortality reduction
				- ARB + neprilysin inhibitor
				- neprilysin inhibition -> prevents inactivation of ANP, BNP, bradykinin, etc

			- spironolactone (MRA)
				- inhibits RAAS + cardiac anti-fibrotic
				- 30% mortality reduction

			- β-blockers
				- reduces sympathetic effects + antiarrhythmogenic
				- 35%

			- SGLT2 inhibitors:
				- reduce blood glucose reabsorption in proximal tubules
				- 26% mortality reduction
				- list:
					- dapagliflozin (farxiga)
					- empagliflozin (jardiance)
			
			- ivabradine (cornalor)
				- reduces heart rate independent of β-blocker effects
				- 18% mortality reduction
				- if HR > 70 bpm

			- tx paradigm:
				- check = BP, HR, K+, creatinine
				- with DM: SGLT2i + ARNi + β-blocker -> 1 week, check -> MRA
				- w/o DM: ARNi + β-blocker -> 1 week, check -> MRA -> 1 week, check -> SGLT2i

		- advanced:
			- heart replacement

	- heart failure with preserved ejection fraction (HFpEF)
		- no therapies improve survival
		- SGLT2i + Aldactone reduce HF hospitalizations
		- diuretics control symptoms
		- BP high -> can use ARNI -> no mortality benefit

	- LHF:
		- orthnopnea, dyspnea, S3 gallop, lung crackles, exhaustion
	- RHF:
		- enlarged liver, ascites, edema, S3 gallops, low BP, elevated JVP

L10: lipid disorders
	main:
	- cholesterol:
		- 1/3 cell membrane
		- substrate for vitamin D
		- precursor to steroid + sex hormones
		- 80% made in liver + intestine
		- 
	- VLDL:
		- carry triglycerides
	- chylomicrons:
		- carry triglycerides
	- LDL:
		- from liver to cells
		- carry cholesterol
	- HDL:
		- from cells to liver
		- carry cholesterol
	- coronary heart disease (CHD)
		- ~50% of deaths in US
		- CVD is #1 cause of women death
			- estrogen decreases LDL by increasing catabolism + increasing HDL
		- pathway:
			- high LDL
			- LDL -> intima infiltration
			- oxidative modification of LDL
			- macrophages
			- foam cells
			- fatty streak
			- endothelial injury
			- adherence of platelets
			- release of PDGF
			- advanced fibrocalcific lesion

		- standard values:
			- normal total cholesterol <200, 200-239 borderline
			- normal LDL < 140, <70 for CHD or DM, >160 high
			- HDL > 40  men, > 60 women
			- normal TGs < 150, 150-199 borderline, 200-499 high, >500 very high

		- measurement:
			- LDL = total cholesterol - VLDL - HDL where VLDL = TGs / 5 (friedewald)
			- martin/hopkin method more accurate

		- risks:
			- htn
			- smoking
			- family hx of CHD (<55 y men or <65 y women)
			- diabetes
			- high LDL
			- low HDL

		- screening:
			- high risk at 25y men or 35y women
			- low risk at 35y men or 45y women
			- diabetics

		- familial hypercholesterolemia
			- defects in LDL receptor processing
				- LDLR mutation
				- ApoB-100 mutation
				- PCSK9 gain of function

			- total cholesterol > 300, LDL > 200
			- xanthomas
			- early onset CAD
			- CVD risk: 25% women, 50% men
			- dx:
				- first degree relative < 55 men or <65 women
				- LDL > 190 in adults, > 160 children
					- LDL > 120 if treated
			- tx:
				- potent statins as young as 8 yo
				- ezetimibe + PCSK9 inhibitor + statin
				- homozygotes / no LDLR activity
					- tx: LDL apheresis, liver transplant, ileal bypass, portocaval shunt
		- Lp(a):
			- cause premature CVD

		- triglycerides:
			- > 1000 -> pancreatitis
				- common cause of pregnancy related pancreatitis

	- dysbetalipoproteinemia
		- autosomal recessive apoE2 mut
		- elevated TGs + total cholesterol
		- needs 2nd hit, e.g. hypothyroidism
		- xanthomas, elevated chylomicron remnants + VLDL

	- familial hypertriglyceridemia:
		- autosomal dominant
		- TG 200-500

	- chylomicronemia:
		- autosomal recessive LPL deficiency
		- impaired lypolysis + increased chylomicrons
		- TGs > 2000 for homozygotes
		- symptoms:
			- eruptive xanthomas
			- lipemia retinales
			- pancreatitis
			- hepatosplenomegaly
			- lymphadema
			- memory loss + peripheral neuropathy

	- ApoA-1 deficiency:
		- absence of HDL
		- free cholesterol elevated
		- corneal opacities, plantar xanthomas
		- missense -> low HDL
		- some ApoA-1 mutations -> amyloidoses

	- tangier disease:
		- ABCA1 deficiency
		- low HDL, LDL, and apoA-1
		- hepatosplenomegaly, orange tonsils, peripheral neuropathy
		- increased CVD risk

	- LCAT deficiency:
		- LDL high, TGs high, HDL + apoA-1 low
		- complete deficiency: hemolytic anemia + ESRD
		- partial deficiency: fish-eye disease

	- CETP deficiency:
		- high HDL (>150)
		- homozygotes in Japan

	- familial combined hyperlidermia:
		- autosomal dominant
		- overproduction of apoB -> VLDL + LDL are small + more atherogenic
		- high LDL + TGs
		- ~20% of premature CAD

	- metabolic syndrome:
		- increased risk for DM2, CVD, + all cause mortality
		- crieria:
			- waist >= 40", >= 35"
			- TGs >= 150
			- HDL < 40, <50
			- htn
			- fasting glucose >= 100

	- drugs:
		- statins
			- inhibit HMG CoA
			- decrease LDL by 30%-60%, mild increase in HDL
			- decrease TGs by 14%-33%
			- effective, decrease CHD risk
				- 22% reduction in mortality
				- 32% reduction in nonfatal MI or CHD
			- side effects:
				- myopathy
				- proteinuria
				- diabetes
				- rare hepatotoxicity

			- list:
				- atorvastatin
				- rosuvastatin
				- simvastatin
				- fluvastatin
				- pravastatin
				- lovastatin

		- cholesterol absorption inhibitor:
			- decreased LDL 17%, 14% w/ statin
			- side effects:
				- increased LFTs w/ statin
				- myalgias / rhabdo
				- hepatitis
				- pancreatitis
				- thrombocytopenia
			- list:
				- ezetimibe

		- bile acid sequesterants
			- cholesterol cannot be absorbed
			- decreases LDL 25%, 50% synergy w/ statin
			- side effects:
				- GI symptoms
				- increase in LFTs
				- decreased fat soluble vitamins
				- decreased absorption of medications

			- list:
				- cholestyramine
				- colestipol
				- colesevelam

		- PCSK9 inhibitors
			- prevent endocytosis of LDL-R
			- reduce LDL by 70%, 60% w/ statin
			- side effects:
				- injection site reaction
				- myalgia
				- neurocognitive events
				- opthamologic events
			- list:
				- evolocumab
				- alirocumab
		- niacin:
			- reduce LDL 25-35% and HDL by 20%
			- side effects:
				- flushing in 80%
				- myopathy w/ statins
				- liver toxicity
				- hyperglycemia
				- gout attack
				- hypotension w/ vasodilators
			- list:
				- niacor
				- niaspan
		- fenofibrates
			- lower TGs by 35-50%, raise HDL by 5-20%
			- mild LDL reduction
			- pancreatitis prevention
			- side effects:
				- muscle toxicity (worse w/ statin)
				- inhibits CYP3A4 -> increases statin concentration
				- decreases cyclosporine
				- increases warfarin
			- list:
				- gemfibrozil
				- fenofibrate

		- fish oil + omega-3 FA
			- reduces TGs by 25%-30%
			- side effects: GI -> nausea
			- no CVD benefit

		- bempedoic acid
			- reduce LDL by 15%
			- secondary prevent for statin intolerant
			- side effects:
				- nasopharyngitis
				- myalgia
				- URT infections


L11: treatment of lipid disorders
	main:
	- tx paradigm
		- CAC: 0 -> no statin unless DM2, FHx, or smoker
		- CAC: 1-99 -> favors statin, especially over 55 yo
		- CAC: 100+ or 75%+ -> statin

L12-13: coronary artery pathophysiology
	- main:
	- myocardial O2 demand
		- wall tension -> increased O2 demand
		- heart rate
		- contactility

	- myocardial O2 supply ~ blood supply
		- diastolic perfusion pressure
		- coronary vascular resistance
			- external compression
				- highest in systole
				- related to intramyocardial pressure
				- subendocardium, next to high intraventricular pressure
					- high risk for ischemic damage

			- perfusion pressure has plateau effect on coronary flow rate
			- regulation
				- local metabolites:
					- oxygen -> vasoconstrictor
					- adensoine -> vasodilator
					- lactate
					- prostaglandins
					- H+
				- endothelial factors,  all -> vasodilation
					- ATP, ADP, bradykinin, histamine, acetylcholine
					- EDRF -> stimilates SMC g cyclase
					- increased cGMP
				- dysfunctional endothelium -> platelet aggregation + vasoconstriction
	
		- O2 carrying capacity
	
	- EKG abnormalities:
		- subendocardial ischemia
			- ST depression (horizontal)
				- worse mortality
			- ST depression (downsloping)
			- T wave inversion

		- transmural ischemia
			- ST elevation

	- unstable angina classifications
	- plaque ruptures risks:
		- <50% initial stenosis -> higher risk for MI + unstable angina
		- more lipids in plaque -> higher rupture risk
		- lower smooth muscle cell count -> higher rupture risk
		- higher macrophage count -> higher rupture risk
		- thinner cap -> higher rupture risk

	- 325mg asprin -> good for MI
	- stopped at slide 85/126

L14-15: valvular heart disease
	- aortic stenosis:
		- > 50% closure -> flow limiting -> htn
		- compensation:
			- concentric LVH
		- decompensation:
			- LVH -> decreased LV compliance
			- hypertrophy / afterload mismatch
			- decrease contractility
		- symptoms:
			- angina
				- increased myocardial O2 demand
				- reduce perfusion, coronary perfusion = aortic pressure - LV diastolic pressure
			- syncope
				- less SV increase during exercise -> decreased CO
			- dyspnea -> CHF
				- increased LVDP -> increased PCWP -> pulmonary congestion / edema
		- progression:
			- 70-80 yo, 50-60 if bicuspid
		- signs:
			- S4: sustained LV apical impulse
			- harsh systolic ejection at R 2nd intercostal
			- reduced A2
			- paradoxical splitting of S2, single S2
			- late peaking crescendo-descrescendo systolic murmur
		- severity:
			- severe: valve area < 1, mean gradient > 4, jet velocity > 4
		- causes:
			- calcific (age)
			- rheumatic heart disease
			- bicuspid
			- unicuspid
			- severe at birth
		- tx:
			- SAVR
			- TAVR
			- balloon aortic valvuloplasty
			- statins to delay AS

	- aortic regurgitation:
		- causes:
			- leaflet abnormality
			- dilatation of aortic root
		- acute:
			- large increase in LV pressure
			- pulmonary congestion
			- decreased CO -> death
			- signs:
				- shock
				- respiratory failure
			- progression: pulmonary congestion -> low CO -> death (hrs to days)

		- chronic:
			- normal CO and LVDP -> asymptomatic
			- increase in LV pressure -> eccentric LVH
				- increased LV size allows larger regurg volume
				- increased SV -> increases systolic BP

			- widened pulse pressure 
				- high SV -> high aortic systolic BP
				- large regurgitant volume -> decrease diastolic BP
			- signs:
				- dyspnea
					- increased LVEDV -> increased LVEDP -> increase LAP -> increased PWCP
					- decreased myocardial contractility -> increased LVEDV - > increased LAP -> increased PWCP
				- fatigue
					- LV failure + decreased CO
				- angina (rare)
					- increased afterload -> increased O2 demand 
					- decreased coronary perfusion pressure
			- exam:	
				- blowing decrescendo diastolic murmur LLSB
				- low feqruency diastolic rumble
				- displaced hyperdynamic LV impulse

			- severity:
				- severe: regurg volume >= 60cc, RF >= 50%, effective regurg orifice >= .30

			- progression: low risk until symptoms -> symptom onset -> irreversible LV dyfunction or death in 1-5 yrs
			- tx:
				- TAVR - clipping
	- mitral valve:
		- papillary muscles
			- antero-lateral: one body, dual supply from LAD + branch of LCx
			- postero-medial: two bodies, supply from LCx or RCA

	- mitral stenosis
		- causes:
			- rheumatic heart disease
			- congenital causes
			- endocarditis
			- mitral annular calcification
			- LA myxoma, thrombus
		- effects:
			- high LA pressure
			- pulmonary edema
			- PH: from backwards pressure
				- PH -> increase constriction -> fibrosis -> more PH
			- atrial dilitation
				- higher risk for afib
		- symptoms:
			- dyspnea
			- exercise intolerance
				- increased flow + HR -> reduced filling time
			- pulmonary edema
			- gradual or acute
				- acute causes: afib, fever/infection, hyperthyroidism, pregnancy, anemia, etc
			- hemoptysis
		- exam:
			- increased S1
			- opening early diastolic snap (earlier -> worse)
			- diastolic rumble (longer -> worse)
			- PH signs: RV heave, increased P2

		- severity:
			- severe: mean gradient >10 mmHg, MVA < 1 cm2, PASP > 50 mmHg
			- normal: mean gradient <5 mmHg, MVA > 1.5 cm2, PASP < 30 mmHg

		- progression:
			- latent, high survival
			- 10 y survival asymptomatic > 80%
			- 10 y survival symptomatic = 50%
				- if severe PH < 3 years

		- tx:
			- diuretics
			- rate/rhythm control for afib
			- anticoagulation for afib
			- valvuloplasty
			- surgical mitral valve repair

	- mitral regurgitation
		- causes:
			- dilation of ventricle + annulus
			- myxomatous, fibroelastic deficiency
			- endocarditis
			- rheumatic heart disease
			- ruptured chords or papillary muscles
		- effects:
			- elevated LA volume + pressure
			- decreased CO
			- LV volume stress
		- severity:
			- regurg orifice size
			- LV - LA pressure
			- LA compliance
			- regurg duration
			- SVR
		- tall V wave on venous tracing
		- acute:
			- normal size, noncompliant LA
				- increased LA pressure
				- increased PWCP -> PH + pulmonary edema
			- decreased CO
			- potential RV failure from PH
			- emergency -> pulmonary edema + shock + death
				- emergency surgery
		
		- chronic:
			- LAE
			- eccentric LVH
			- same CO
			- symptoms:
				- fatigue
				- dyspnea: elevatred LAP -> increased PWCP
				- afib: LA volume overload, pressure overload
				- RHF symptoms: late
		- exam:
			- holosystolic murmur at apex, radiating to axilla
				- worsens with fist clench (increased afterload)
			- chronic MR:
				- displaced, diffused apex
				- S3 (audible + palpable)
		-  severity:
			- severe: regurg volume >= 60cc, RF >= 50%, effective regurg orifice >= .40
		- progression:
			- onset -> irreversible LV dysfunction, CHF, death in several yrs
		- tx:
			- diuretics
			- afterload reduction: all acute or only hypertensive chronic
			- MV repair if structural
			- function MR -> treat underlying cause

	- tricuspid regurgitation
		- causes:
			- RV dilitation
			- endocarditis
			- carcinoid syndrome -> endocardial plaques on right heart

	- PV loops:
		- aortic stenosis: increased pressure, LVEDV -> shift right, LVESV stays same
		- aortic regurg: pressure ~ same, LVESV -> shifts right, loop widens in volume
		- mitral stenosis: LVESV -> shifts left
		- mitral regurg: loop widens in volume

L15B: valve pathology:

L16-17: cardiac arrhythmias
	main:
	- normal sinus rhythm
		- sinus node -> AV node -> His-purkinje system
		- p wave positive in II and negative in aVR

	- arrhythmia mechanisms:
		- automaticity
			- leaky membranes -> partial depolarization
			- automatic rate > SA node rate -> ectopic beats
			- ex: PACs, PVCs, junctional tachycardia, atrial tachycardia

		- triggered activity
			- afterdepolarization: one depolarization triggering other depolarizations
			- high voltagea afterdepolarization -> ectopic beats or tachyarrythmias
			- early afterdepolarization:
				- phase 2: augmented inward Ca
				- phase 3: augmented inward Na
				- usually in prolonged repolarization, such as long QT
				- arrhythmia: torsades des pointes 

			- delayed afterdepolarization:
				- phase 4: augmented inward Ca
				- situations: 
					- digoxin toxicity -> elevated intracellular Ca
					- catecholamine stimulation
					- resulting arrhythmia: bidirectional/ideopathic VT

		- altered impulse conduction
			- causes: ischemia, fibrosis, drugs
			- block: impulse reachs unexcitable area
				- transient vs permanent
				- bidirectional vs unidirectional 
				- complete block -> bradyarrhythmias
			- reentry:
				- unidirectional block that loops -> tachyarrhythmia
				- self-perpetuating reentry:
					- unidirectional block
					- conduct flows retrograde through block and reenters loops
					- ex:
						- AVNRT
						- AVRT
						- atrial flutter
						- scar-related VT
					- causes:
						- decreased conduction velocity
							- scarring, MI, cardiomyopathies
						- heterogenous refractoriness
							- MI, inflammation, cardiomyiopathies, electrolyte abnormalities
	
	- general treatment ideas:
		- decrease automaticity (phase 4 slope)
			- β-blockers + CCBs
		- decrease conduction velocity (phase 0 slope)
			- Na + K blockers
		- change refractory period: prolong phase 2 + 3
			- Na + K blockers


	- common tachyarrhythmias:
		- sinus tachycardia:
			- causes: fever, hyperthyroidism, volume depletion, anxiety, etc
			- tx: can use β-blocker

		- premature atrial complex/contraction (PAC):
			- P wave from other atrial focus
				- different morphology
				- earlier in cycle
			- skipped beats, palpitations, benign
			- tx: reassurance, maybe β-blockers

		- atrioventricular nodal reentrant tachycardia (AVNRT):
			- two paths: fast + slow
			- usually symptomatic: onset/offset of regular palpitations
			- EKG: dont know

		- atrioventricular reentrant tachycardia (AVRT):
			- bypass path
			- delta wave: elongated pre R wave slope
			- widened QRS

		- wolf-parkinson-white syndrome (WPW):
			- delta waves
			- orthodromic AVRT:
				- path from outside LV through atria back to septum
			- antidromic AVRT:
				- path up septum then down outside of LV
				- widened R, two peaks

		- focal atrial tachycardia:
			- single site of origin

		- multifocal atrial tachycardia:
			- >=3 sites of origin
			- >=3 P wave shapes 

		- atrial fibrillation:
			- SVT w/ >350 bpm
			- irregular + disorganized atrial activity
				- no discrete P waves
			- causes:
				- altered atrium: fibrosis, inflammation, enlarged
				- altered atrial refractoriness:
					- hyperthyroidism
					- alcohol, stimulants
					- vagal tone
			- tx:
				- rate control:
					- chronic AF, few symptoms, multiple co-morbidities
					- previous antiarrhythmic failure
				- rhythm control:
					- paroxysmal afib
					- highly symptomatic, younger, CHF worsened by afib
					- meds:
						- amiodarone: thyroid, liver, pulm, ocular toxicities
						- sotalol/dofetilide: long QT/torsade
						- flecainide/propafenone: avoid w/ other heart disease
						- dronedarone: not w/ severe CHF, permanent afib or cirrhosis
				- CHADS-VASC: >=2 men or >=3 women -> give oral anticoagulant

		- atrial flutter:
			- starts RA revolves around tricuspid valve
			- sawtooth F waves
			- tx: just look at chart

		- junctional rhythms / tachycardia:
			- increased automaticity at AV node > sinus node
			- lack of P waves
			- causes:
				- digoxin toxicity
				- beta-agonists: isoproterenol
				- beta-blockers
				- MI, myocarditis, cardiac surgery
			- junctional escape beat:
				- single beat missing P wave
			- junctional rhythm:
				- regular: 40-60 bpm
				- accelerated: 60-100 bpm
			- junctional tachycardia:
				- >100 bpm

		- supraventricular tachycardias:
			- paroxysmal (PSVT):
				- acute:
					- unstable: cardioversion (synced)
					- stable:
						- CSM/vagal maneuvers/adenosine -> stop PSVT
						- CCBs or β-blockers to terminate

				- chronic:
					- counsel to avoid triggers: caffeine, alcohol, pseudophedrine, stress
					- AV nodal blockers
					- catheter ablation or antiarrhythmics

			- irregular ventricular rate:
				- multifocal atrial tachycardia
				- afib
				- atrial flutter / variable AV block
				- atrial tachycardia / variable AV block

			- regular ventricular rate:
				- no P waves:
					- AVNRT
					- junctional tachycardia
				- P waves:
					- sinus tachycardia
					- atrial tachycardia
					- atrial flutter + 2:1/3:1/4:1 AV block
					- AVNRT / AVRT

		- premature ventricular complex/contraction (PVC):
			- no P wave, wide QRS, T wave polarity opposite of PVC

		- ventricular tachycardia:
			- non-sustained:
				- >= 3 ventricular beats w/ rate >= 100 bpm
				- tx:
					- symptomatic -> antiarrhythmics
					- heart disease -> refer for ICD implant

			- sustained:
				- > 30 seconds of ventricular beats
				- tx:
					- acute:
						- unstable -> DC cardiovert
						- lidocaine
						- procainamide: watch for hypotension
						- amiodarone
					- chronic:
						- β-blocker
						- amiodarone or sotalol: palliative
						- ICD
						- catheter ablation: curative in ideopathic, palliative in advanced heart disease

		- torsades de pointes:
			- polymorphic ventricular tachycardia (VT)
			- setting: long QT interval
			- tx:
				- acute:
					- defibrillate
					- check K+ / Mg
					- isoproterenol or pacemaker to 100 bpm
					- lidocaine
					- stop offending meds
				- long term:
					- genetic testing
					- β-blockers
					- ICD
					- avoid QT-prolonging meds

		- ventricular fibrillation:
			- chaotic disorganized ventricular rhythm
			- tx: defibrillate
			-

	- common bradyarrhythmias:
		- tx:
			- asymptomatic: nonthing
			- symptomatic:
				- stop offending meds
				- short term: atropine
				- pacemaker

		- sinus bradycardia:
			- <60 bpm

		- AV block:
			- 1st degree:
				- PRi > 200 ms (5 mm)
				- wide QRS -> risk of higher degree block
			
			- 2nd degree type I - wenckebach:
				- PRi prolongation -> non-conduction of P wave (P wave w/o QRS)
				- caused by: β-blockers, CCBs, digoxin
				- usually asymptomatic: sometimes angina, syncope (elderly)

			- 2nd degree type II:
				- normal PRi with sudden non-conduction of P wave (no QRS)
				- usually below AV node w/ BBB or fascicular block
				- symptoms: pre/syncope, worse with exercise
				- tx: pacemaker

			- 3rd degree:
				- complete AV dissociation, atrial rate > ventricular rate
				- symptoms: dizziness, syncope, angina, HF
				- tx: pacemaker

	- tachy-brady syndrome:
		- symptoms: bradycardia, lightheadness, syncope, palpitations, etc
		- tx:
			- antiarrhythmic + pacemaker
			- anticoagulation w/ afib or aflutter

	- sick sinus syndrome:
		- HR too low -> reduced CO
		- symptoms: bradycardia, lightheadness, syncope, fatigue, chest pain

	- pacemaker guide:
		- symptomatic + bradycardia cause -> pacemaker
		- asymptomatic + HR in 30s + >3s pauses -> pacemaker
		- asymptomatic + high risk for progression (type II AV block) -> pacemaker

	- ICD guide:
		- spontaneous sustained VT + structural heart disease
		- cardiac arrest from VT or VF
		- syncope of unkown origin + sustained VT or VF when drugs not option
		- LVEF <35%, at least 40 days post MI, NYHA class II-III
		- prior MI, LVEF < 40%, NSVT and inducicle VT


L18: cardiac genetics:
	main:
	- trisomies 13, 18, 21 -> increased risk of CHD
	- DiGeorge syndrome (TBX1):
		- truncus arteriosus
		- tetralogy of fallot
		- VSD
	
	- williams syndrome (ELN):
		- hypercalcemia
		- peripheral PA stenosis
	
	- elastin
		- isolated peripheral pulmonic stenosis
	
	- alagille syndrome (JAG1)
		- stenosis of the branched pulmonary arteries
		- jaundice (paucity of bile ducts)
	
	- noonan syndrome/leopard syndrome (PTPN11)
		- dysplastic pulmonary valve, hypertrophic cardiomyopathy
		- short stature
	
	- holt-oram syndrome (TBX5)
		- arm/hand birth defects
		- atrial septal defects most common
		- conduction abnormalities
	
	- marfan syndrome
		- aortic root dilation

	- isolated hypertrophic cardiomyopathy:
		- autosomal dominant
		- variable penetrance w/ age
		- place ICD
	
	- dilated cardiomyopathy:
		- associated with muscular dystrophy
		- LMNA mutation -> conduction disease -> AICD

	- arrhythmogenic right ventricular cardiomyopathy (ARVC):
		- fibro-fatty replace of RV myocardium
		- monomorphic VTs w/ LBBB
	
	- familial long QT
		- QTc > 440ms
		- autosomal dominant, autosomal recessive w/ deafness
		- results in polymorphic VTs -> torsades
		- mechanisms: slow repolarization
			- decreased K channel activity
			- increased Na channel activity
		- types:
			- LQT1:
				- emotion, physical activity
				- β-blockers
				- restrict activity
			- LQT2:
				- auditory stimuli, sleep or rest
				- avoidance of hypokalemia + auditory triggers
			- LQT3:
				- sleep or rest
				- mexiletine/flecainide
				- pacing / AICD

	- brugada syndrome:
		- RBBB w/ ST elevation in V1-V3
		- SCD from VF during sleep
		- defibrillator

	- catecholaminergic polymorphic ventricular tachycardia (CPVT):
		- bi-direction polymorphic VT w/ exercise, stress, catecholamines
		- degenerates -> malignant VT + cardiac death
		- 30% mortality by 30 yo
		- autosomal dominant: ryanodin 2 (RyR2)
		- autosomal recessive: calsequestrin (CASQ2)
		- tx: β-blockers + AICD


L19: sudden cardiac death:
	main:
	- <= hour from symptom onset
	- SCD = VT or vfib
	- causes:
		- MI
		- brugada:
			- convex ST elevation w/ negative T waves in V1-V3
		- wolf-parkinson-white
		- commotio cordis: heart stops when hit
	- risks:
		- look for VT symptoms
		- murmurs portend -> HCM
		- CHF / cardiomyopathy
		- EF is biggest predictor of survival
	- electrophysiology study (EPS):
		- catheter pacing -> induce VT
	- tx:
		- class I: lidocaine IV, mexiletine, quinidine
		- class III: sotalol, dofetilide
		- amiodarone
		- AICD
			- prior cardiac arrest
			- HF w/ low EF
			- MI w/ low EF + inducible VT
			- high risk channelopathies
			- HCM w/ high risk features


L20: cardiomyopathies:
	main:
	- dilated:
		- systolic dysfunction
		- peripartum cardiomyopathy
			- last trimester + 6 mo postpartum
			- recovers in 50%

		- stress induced cardiomyopathy: broken heart syndrome, takotsubo
			- LV apical ballooning
			- may resolve days to months

		- criteria:
			- CXR: normal, cardiomegaly, pulmonary edema, pleural effusions
			- EKG: afib, LBBB, VT
			- endomyocardial bx:
				- myocarditis: giant cell, lymphocytic, eosinophilic, CMV, toxoplasmosis

		- tx:
			- volume control: salt restriction + loop diuretics
			- vasodilators: ACEi, ARB, ARNI, hydralazin + nitrates
			- β-blockers: coreg, metoprolol, bisoprolol
			- MRA: aldactone, eplerenone
			- SGLT 2: dapagliflozin or empagliflozin

	- hypertrophic:
		- diastolic dysfunction
		- LVH that is NOT caused by pressure overload (htn or aortic stenosis)
		- pathophysiology:
			- diastole: reduced filling + increased filling pressure
			- MI: increased O2 demand, decreased vasodilator reserve, systolic compression of coronaries
			- mitral regurg
			- arrhythmias
		
		- dynamic LVOT obstruction
			- septal bulge
			- MV large and slack
			- residual leaflet extension
		- symptoms:
			- chest pain
			- syncope
			- lightheadness or dizziness
			- palpitations
			- dyspnea
			- fatigue
			- HF
		- signs:
			- S4: LA contraction into stiff LV
			- double apical impulse
			- jerky bifid carotid pulse
			- MR murmur: holosytolic at apex
			- LVOT murmur: crescendo-decrescendo LLSB 
				- dynamic murmur:
					- louder w/ vasalva
					- quieter w/ squatting
		- tx:
			- β-blockers: metoprolol
				- decrease O2 demand
				- reduce exercise LVOT gradient
				- increased diastolic filling time
			- non-dihydropyridine CCBs: verapamil + diltiazem
				- if intolerant to β-blockers
			- antiarrhythmics:
				- disopyramide (norpace): reduces resting LVOT gradient
				- amiodarone
			- surgery: myectomy, MV plication, alcohol septal ablation

			- avoid:
				- nitrates
				- ACE / ARBs (*prils and *sartans)
				- dihydropyridine CCBs: nifedipine, amlodipine, *pines
				- α-blockers (*sins)
				- PDE5i (*enafils)
				- dobutamine, dopamine, digoxin
				- sympathomimetics

	- restrictive:
		- diastolic dysfunction
		- impairsed diastolic filling + preserved systolic fxn
		- pathophysiology:
			- EDVPR shifts left -> small PV loop
			- high diastolic pressures
			- elevated pulmonary + systemic pressure
			- reduced LV size, SV, CO
		- causes:
			- sarcoid
			- amyloidosis:
				- AL: plasma cell dyscrasia
				- TTR-hereditary: autosomal dominant, transthyretin -> amyloid fibrils
				- TTR-senile: transthyretin -> amyloid deposits everywhere
				- AA: inflammatory marker amyloid A -> AA amyloid, RA, etc
				- signs:
					- EKG:
						- reduced voltage
						- afib
						- pseudoinfarct
						- AV conduction abnormality
					- echo:
						- thick LV + RV walls
						- biatrial dilatation
						- pericardial effusion
						- valve thickening w/o dysfunction
					- MRI: global subendocardial hyperenhancement
					- nuclear SPECT
					- blood test: monoclonal gammopathy -> AL amyloidosis
				- tx: 
					- diuretics
					- challenging meds: β-blockers, ACEi, ARB, digoxin, CCBs
					- high dose chemo + stem cell transplant
					- TTR:
						- tafamidis
						- patisiran
						- inrotesen

			- hemochromatosis
			- radiation carditis
			- LV noncompation
				- treat with anticoagulation + HF treatment
			- arrhythmogenic RV cardiomyopathy
				- adipose + fibrous RV replacement

L21: social determinants of health:
	main:
	- NSTEMI care differences

L22: pericardial diseases:
	main:
	- congenital absence pericardium
	- acute pericarditis:
		- progression:
			- local vasodilation: transudative effusion
			- increased vascular permeability: exudative effusion
			- leukocyte infiltration: neutrophils + mononuclears

		- pathology:
			- serous: scant cellular infiltrate
			- serofibrous: fibrinous loculations "bread + butter appearance"
			- suppurative (purulent): intense inflammatory exudate
			- hemorrhagic: bloody effusion
		
		- symptoms:
			- chest pain: "stabbing, sharp"
				- restrosternal or left-sided -> radiates to neck, shoulder, left scapula
				- pleuritic
				- positional: relieved when sitting upright / forward

			- dyspnea
			- fever
			- viral symptoms
		- signs:
			- friction rub, best heard at left sternal border
			- EKG:
				- diffuse ST elevation, concave upward
				- PR depression
				- late: diffuse T-wave inversion
			- labs: elevated WBSC, lymphocytes, ESR, CRP, cardiac enzymes

		- tx:
			- acute viral:
				- NSAIDs
				- colchicine: decreases recurrence rate
				- corticosteroids: not first line

	- pericardial effusion:
		- symptoms:
			- dull, left chest discomfort
			- compression symptoms:
				- dyspnea
				- throat pain / dysphagia
				- hoarseness
				- hiccups
		- signs:
			- distant + muffled heart sounds
			- ewart sign: dullness to percussion of lung below left scapula
			- friction rub
			- EKG: low voltages, electrical alternans (alternating QRS sign)
			- CXR: fluid, water bottle heart
			- echo: sensitive
		- tx:
			- tx underlying cause: dialysis for uremic effusion
			- pericardiocentesis
	
	- cardiac tamponade:
		- increase intrapericardial pressure
		- compression: prevents filling + venous return
		- decreased SV + CO
		- elevated diastolic pressure
		- compensatory mechanisms -> failure leads to shock + death:
			- increased sympathetic tone
			- tachycardia
			- peripheral vasoconstriction
			- volume expansion
		- symptoms:
			- fatigue
			- vague chest discomfort
			- dyspnea, cough
			- lightheadness, syncope
			- symptoms of shock
		- signs:
			- beck's triad: JVD, hypotension, "small, quiet heart"
			- sinus tachycardia
			- pulsus paradoxus
			- dyspnea + tachypnea
			- shock
			- echo: visualize
			- CT: loculated effusion
			- cardiac cath: definite study

		- tx:
			- volume resuscitation
			- pericardiocentesis
			- pericardiostomy

	- pericardial constriction:
		- rigid, scarred pericardium
		- symptoms:
			- fatigue
			- hypotension
			- tachycardia
			- JVP
			- hepatomegaly
			- pedal edema
		- signs:
			- reduced CO
			- elevated venous filling pressure
			- early diastolic pericardial knock
			- kussmaul's sign
			- rapid Y descent
			- CXR: calcification
			- CT / MRI: pericardial thickening >2mm
			- doppler echo:
				- abnormal diastolic filling pattern
				- abnormal septal motion
				- respiratory variation inflow velocities
			- cardiac cath:
				- elevation / equalization of diastolic pressures
				- prominent Y descent in RA
				- early diastolic "dip and plateau" in RV + LV pressures
				- discordant RV + LV systolic pressure with breaths
			- tx:
				- pericardectomy: significant mortality (6%)


L23: left to right shunts:
	main:
	- fetal circulation:
		- O2 -> umbilical vein -> ductus venosus -> IVC
		- PFO: RA O2 -> LA O2
		- pulmonary blood flow <10%
		- ductus arteriosus: PA O2 -> aorta

		- RV 66% CO: 60% -> DA

	- ventricular septal defect (VSD):
		- effects:
			- large: CHF, softer murmur
			- small: None, louder murmur
		- harsh systolic murmur at LLSB
		- precordial thrill secondary to turbulence across VSD
		- mid-diastolic rumble secondary to trans-mitral flow
		- LVH / CHF: S3, hepatomegaly, rales
		- pulm vasc disease: RV heave, loud S2, cyanosis
		- O2 step up in RV
		- digoxin + lasix + calories -> fail -> surgery
		- endocarditis prophylaxis 6 mo post surgery, for life if defect, before oral surgery

	- PDA:
		- effects:
			- small: asymptomatic
			- large: CHF
			- moderate: fatigue + dyspnea + SVT secondary to LAE
		- continuous machine like murmur
		- LAE, LVH, O2 step up in PA
		- PH or CHF or FTT -> closure -> indomethacin or surgical ligation or coil

	- ASD:
		- RA + RV volume overload
		- effects:
			- kid: asymptomatic
			- adult (before 40 yo):
				- atrial tachycardia secondary to RAE
				- RHF
				- survival less (50-60s)
		- wide, fixed split S2, RV heave
		- systolic murmur LUSB
		- mid-diastolic murmur LLSB
		- RAE, RVH, RVD, IRBBB, O2 step up in RA
		- RV volume overload or TE -> closure



L24: right to left shunts:
	main:
	- tetralogy of fallot (ToF):
		- features:
			- VSD
			- aortic override (centered between ventricles)
			- pulmonary stenosis
			- RVH
		- causes: DiGeorge
		- systolic ejection murmur at LUSB
		- tx: surgical repair of VSD + PS
		- boot heart + upturned apex

	- truncus arteriosus (TA):
		- features:
			- aorta + PA combined
			- VSD
		- PH high risk
		- surgical repair

	- transposition of the great arteries:
		- great arteries switched
		- survival by PFO/ASD, VSD (1/3) or PDA
		- tx:
			- balloon atrial septostomy
			- surgical arterial switch
